Meet OrgaNext CEO in Canada
In honour of the visit of Prime Minister Mark Rutte to Canada On October 25, 2018 , OrgaNext has been invited to join a business delegation to Toronto and Ottawa on respectively October 24 and October 25 2018. “Especially since we recently received also in Canada a patent for our regenerative medicine NDD, we are delighted to join this delegation. The CETA agreement offers great opportunities to work with Canadian Academic institutions and Life Science partners. With comparable healthcare systems in both countries we see opportunities for joint clinical development and thus to accelerate access to patients with unmet needs in both the EU and Canada” according to Marjanne Prins, CEO of OrgaNext Research.